Chengdu Huasun Technology Group Inc., Ltd. (000790.SZ)

CNY 3.39

(-3.14%)

EBITDA Summary of Chengdu Huasun Technology Group Inc., Ltd.

  • Chengdu Huasun Technology Group Inc., Ltd.'s latest annual EBITDA in 2023 was 74.04 Million CNY , down -3.96% from previous year.
  • Chengdu Huasun Technology Group Inc., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 9.75 Million CNY , down -57.56% from previous quarter.
  • Chengdu Huasun Technology Group Inc., Ltd. reported an annual EBITDA of 80.18 Million CNY in 2022, down -6.81% from previous year.
  • Chengdu Huasun Technology Group Inc., Ltd. reported an annual EBITDA of 86.12 Million CNY in 2021, up 33.89% from previous year.
  • Chengdu Huasun Technology Group Inc., Ltd. reported a quarterly EBITDA of 9.75 Million CNY for 2024 Q3, down -57.56% from previous quarter.
  • Chengdu Huasun Technology Group Inc., Ltd. reported a quarterly EBITDA of 9.19 Million CNY for 2024 Q1, up 30.96% from previous quarter.

Annual EBITDA Chart of Chengdu Huasun Technology Group Inc., Ltd. (2023 - 1995)

Historical Annual EBITDA of Chengdu Huasun Technology Group Inc., Ltd. (2023 - 1995)

Year EBITDA EBITDA Growth
2023 74.04 Million CNY -3.96%
2022 80.18 Million CNY -6.81%
2021 86.12 Million CNY 33.89%
2020 68.92 Million CNY -18.33%
2019 92.01 Million CNY 32.67%
2018 68.42 Million CNY -0.06%
2017 255.7 Million CNY -53.0%
2016 143.95 Million CNY 273.02%
2015 6.08 Million CNY -68.85%
2014 118.85 Million CNY 49.79%
2013 84.47 Million CNY 4.53%
2012 65.48 Million CNY 37.95%
2011 55.07 Million CNY 5.53%
2010 46.9 Million CNY 14.48%
2009 40.48 Million CNY 31.81%
2008 31.56 Million CNY 17.68%
2007 22.94 Million CNY 3.95%
2006 32.45 Million CNY 3.29%
2005 29.15 Million CNY 1.88%
2004 28.71 Million CNY -7.03%
2003 30.74 Million CNY -23.79%
2002 40.33 Million CNY -9.32%
2001 44.47 Million CNY 1.54%
2000 39.82 Million CNY 28.99%
1999 33.95 Million CNY -24.24%
1998 44.35 Million CNY 8.95%
1997 41.13 Million CNY 34.26%
1996 30.64 Million CNY 91.94%
1995 15.96 Million CNY 0.0%

Peer EBITDA Comparison of Chengdu Huasun Technology Group Inc., Ltd.

Name EBITDA EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd. -141.51 Million CNY 152.324%
Anhui Fengyuan Pharmaceutical Co., Ltd. 388.66 Million CNY 80.949%
Dong-E-E-Jiao Co.,Ltd. 1.53 Billion CNY 95.19%
Livzon Pharmaceutical Group Inc. 3.29 Billion CNY 97.754%
Hainan Haiyao Co., Ltd. 152.19 Million CNY 51.349%
Tus-Pharmaceutical Group Co., Ltd. 62.18 Million CNY -19.076%
Jilin Aodong Pharmaceutical Group Co., Ltd. 1.87 Billion CNY 96.058%
Changchun High-Tech Industries (Group) Inc. 6.09 Billion CNY 98.785%
Apeloa Pharmaceutical Co.,Ltd 1.79 Billion CNY 95.868%
PKU HealthCare Corp.,Ltd. 132.39 Million CNY 44.072%
Dezhan Healthcare Company Limited 219.36 Million CNY 66.245%
Jinling Pharmaceutical Company Limited 249.63 Million CNY 70.338%
Jiuzhitang Co., Ltd. 460.28 Million CNY 83.913%
Huapont Life Sciences Co., Ltd. 2.12 Billion CNY 96.519%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 945.42 Million CNY 92.168%
Shandong Wohua Pharmaceutical Co., Ltd. 87.98 Million CNY 15.848%
Hengkang Medical Group Co., Ltd. 348.09 Million CNY 78.729%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 453.78 Million CNY 83.683%
Qianjiang Yongan Pharmaceutical Co., Ltd. 141.6 Million CNY 47.712%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 124.71 Million CNY 40.631%
Jinhe Biotechnology CO., LTD. 345.42 Million CNY 78.564%
Teyi Pharmaceutical Group Co.,Ltd 369.46 Million CNY 79.959%
Kunming Longjin Pharmaceutical Co., Ltd. -31.19 Million CNY 337.34%
Beijing Aosaikang Pharmaceutical Co., Ltd. -112.74 Million CNY 165.674%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 1.38 Billion CNY 94.668%
Anhui Huangshan Capsule Co., Ltd. 118.18 Million CNY 37.35%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 166.4 Million CNY 55.504%
Zhuhai Rundu Pharmaceutical Co., Ltd. 215.02 Million CNY 65.564%
Huaren Pharmaceutical Co., Ltd. 431.65 Million CNY 82.846%
Tianjin Ringpu Bio-Technology Co.,Ltd. 711.43 Million CNY 89.592%
Shanxi Zhendong Pharmaceutical Co.,Ltd 94.75 Million CNY 21.855%
Fuan Pharmaceutical (Group) Co., Ltd. 528.99 Million CNY 86.003%
Hybio Pharmaceutical Co., Ltd. -233.61 Million CNY 131.695%
Baotou Dongbao Bio-Tech Co.,Ltd 236.24 Million CNY 68.658%
Hunan Er-Kang Pharmaceutical Co., Ltd 12.02 Million CNY -515.888%
Changjiang Pharmaceutical Group Co., Ltd. -572.69 Million CNY 112.929%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 383.11 Million CNY 80.673%
Fujian Cosunter Pharmaceutical Co., Ltd. -190.85 Million CNY 138.796%
Beijing Science Sun Pharmaceutical Co., Ltd. 7.7 Million CNY -861.243%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 87.94 Million CNY 15.81%
Hainan Poly Pharm. Co., Ltd 309.33 Million CNY 76.063%
Jiangxi Synergy Pharmaceutical Co., Ltd. 192.54 Million CNY 61.543%
Wuhan Hiteck Biological Pharma Co.,Ltd -73.65 Million CNY 200.526%
Shandong Xinhua Pharmaceutical Company Limited 1.09 Billion CNY 93.242%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 435.22 Million CNY 82.987%
PharmaBlock Sciences (Nanjing), Inc. 380.8 Million CNY 80.556%
Jinghua Pharmaceutical Group Co., Ltd. 417.61 Million CNY 82.269%
Zhejiang Hisoar Pharmaceutical Co., Ltd. -43.99 Million CNY 268.307%
Betta Pharmaceuticals Co., Ltd. 696.09 Million CNY 89.363%
Tibet AIM Pharm. Inc. 50.76 Million CNY -45.867%
Shenzhen Kangtai Biological Products Co., Ltd. 1.29 Billion CNY 94.283%
Shandong Shanda Wit Science and Technology Co., Ltd. 1.39 Billion CNY 94.707%
Pacific Shuanglin Bio-pharmacy Co., LTD 841.98 Million CNY 91.206%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 300.14 Million CNY 75.33%
Xiamen Kingdomway Group Company 588.78 Million CNY 87.424%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 127.06 Million CNY 41.727%
Walvax Biotechnology Co., Ltd. 938.22 Million CNY 92.108%
Sunflower Pharmaceutical Group Co.,Ltd 1.54 Billion CNY 95.213%
Harbin Gloria Pharmaceuticals Co., Ltd 275.28 Million CNY 73.102%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 4.68 Billion CNY 98.421%
Hunan Hansen Pharmaceutical Co., Ltd. 280.66 Million CNY 73.618%
Changzhou Qianhong Biopharma CO.,LTD 278.66 Million CNY 73.429%
Shenzhen Weiguang Biological Products Co., Ltd. 350.21 Million CNY 78.857%
Honz Pharmaceutical Co., Ltd. 133.53 Million CNY 44.549%
Northeast Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 93.811%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 217.47 Million CNY 65.952%
Guizhou Xinbang Pharmaceutical Co., Ltd. 654.01 Million CNY 88.678%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 477.37 Million CNY 84.489%
Zhejiang Yatai Pharmaceutical Co., Ltd. 76.31 Million CNY 2.973%
Zhejiang NHU Company Ltd. 5.24 Billion CNY 98.589%
ApicHope Pharmaceutical Co., Ltd 464.04 Million CNY 84.043%
Shanghai Kaibao Pharmaceutical CO.,Ltd 375.33 Million CNY 80.272%
Beijing SL Pharmaceutical Co., Ltd. 610.29 Million CNY 87.867%
Yunnan Baiyao Group Co.,Ltd 5.2 Billion CNY 98.578%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 127.72 Million CNY 42.026%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 228.9 Million CNY 67.652%
Guangdong Lifestrong Pharmacy Co., Ltd. 50.95 Million CNY -45.3%
Huadong Medicine Co., Ltd 4.61 Billion CNY 98.396%
Jiangsu Nhwa Pharmaceutical Co., LTD 1.33 Billion CNY 94.47%
Harbin Medisan Pharmaceutical Co., Ltd. 183.66 Million CNY 59.685%
LanZhou Foci Pharmaceutical Co.,Ltd. 135.36 Million CNY 45.301%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 1.04 Billion CNY 92.928%
Beijing Beilu Pharmaceutical Co., Ltd 36.44 Million CNY -103.166%
Nanjing Hicin Pharmaceutical Co., Ltd. 97 Million CNY 23.666%
Renhe Pharmacy Co., Ltd. 1.05 Billion CNY 92.953%
Chongqing Pharscin Pharmaceutical Co., Ltd. 125.84 Million CNY 41.163%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 863.95 Million CNY 91.43%
Luoxin Pharmaceuticals Group Stock Co., Ltd. -320.08 Million CNY 123.133%
Guizhou Bailing Group Pharmaceutical Co., Ltd. -298.6 Million CNY 124.797%